SUBSCRIBERS
Corporate digest
Published Tue, Jul 7, 2015 · 09:50 PM
Cordlife Group
CORDLIFE Group said on Tuesday that it has rejected an unsolicited third party offer for its shares in China Cord Blood Corporation and convertible notes due 2017. Instead, it will proceed with an earlier plan to sell them to Hang Seng-listed healthcare company Golden Meditech.
Digiland International
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Emerging-market optimism dashed by Fed as currencies, bonds sink
LHN warns H1 2024 net profit could decline by 28.6%
iPhone maker Hon Hai’s April sales rise 19% in positive signal
Worsening weather is igniting a US$25 billion market
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules